These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15831270)

  • 1. The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma.
    Kim WR
    Clin Liver Dis; 2005 May; 9(2):225-34. PubMed ID: 15831270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
    Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of hepatocellular carcinoma: challenges and opportunities.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
    [No Abstract]   [Full Text] [Related]  

  • 5. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy.
    Seki S; Sakaguchi H; Iwai S; Kadoya H; Kabayashi S; Kitada T; Fujii H; Tanaka T
    Endoscopy; 2005 Dec; 37(12):1220-5. PubMed ID: 16329021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
    Chen TM; Chang TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e179-88. PubMed ID: 18466287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease.
    Strebel BM; Dufour JF
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1743-9. PubMed ID: 18983234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy.
    Maniaci V; Davidson BR; Rolles K; Dhillon AP; Hackshaw A; Begent RH; Meyer T
    Eur J Surg Oncol; 2009 Jun; 35(6):617-21. PubMed ID: 19144491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primer: using decision analysis to improve clinical decision making in urology.
    Elkin EB; Vickers AJ; Kattan MW
    Nat Clin Pract Urol; 2006 Aug; 3(8):439-48. PubMed ID: 16902520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More options and improved outcomes for hepatocellular carcinoma.
    Scoggins CR
    J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
    Liu Y; Yang R
    J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.